日本肝臓学会

日本肝臓学会の公式アカウントです。学会からのお知らせを情報発信します。 Official account of the Japan Society of Hepatology

[Hepatology Research @HepatolRes]

▶️Liver Fibrosis and Steatosis in Inflammatory Bowel Disease: A Cross-Sectional Matched-Control Transient Elastography Study (ELASTIBD)

👉https://t.co/QG4v29ctw2

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

▶️Identification of the Inflammatory Cytokine Tumor Necrosis Factor Superfamily 4 as an Oncogenic Driver and Potential Druggable Target in Hepatocellular Carcinoma

👉https://t.co/Bfy4NdBAEI

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

▶️The 7S Domain of Type IV Collagen as a Noninvasive Surrogate of Portal Hypertension

👉https://t.co/deYpLEUAqx

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

▶️Oncogenic Signaling Activation and Potential Biomarkers in Congestive Hepatopathy Revealed by Proteomic Analysis

👉https://t.co/zF4j8el5HM

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

▶️Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C Patients

👉https://t.co/4qbpQxkf3K

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

▶️Exploring a Subpopulation of MASLD Associated With New Onset of CKD Using Supervised Clustering Techniques

👉https://t.co/VsPUpcQK6R

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

▶️Machine Learning Approach Enables Highly Accurate Identification of At-Risk Metabolic Dysfunction-Associated Steatohepatitis

👉https://t.co/x53b8F9rHm

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

▶️Effect of Direct-Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japan

👉https://t.co/6H9LY4MDZM

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

▶️Dual Escape From Disulfidptosis and Ferroptosis Drives Highly Aggressive, Hypermetabolic Hepatocellular Carcinoma

👉https://t.co/DspYNAgqBc

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

▶️Clinical Outcomes and Transitional Care Following Endoscopic Variceal Treatment in Pediatric Portal Hypertension

👉https://t.co/g3XyXRB27i

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

▶️Efficacy and Safety of Atezolizumab Plus Bevacizumab Versus Durvalumab Plus Tremelimumab for Unresectable Hepatocellular Carcinoma in Patients With Child–Pugh Class B: A Real-World Study

👉https://t.co/ftCXv8D0uU

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

▶️Post-COVID-19 Changes in Body Composition and Adiposity in Patients With Chronic Liver Disease: A Longitudinal Study From Japan

👉https://t.co/PvXqIR4Lg0

#LiverX @WileyHealth

[横浜市立大学附属病院 国際臨床肝疾患センター YCU liver center @YCU_LiverCenter]

【School of Hepatology in Yokohama 開催のお知らせ🧑‍🎓】
2026/10/11-12に日本肝臓学会@JSHLiverの若手の先生向け研修会を開催します！
テーマは『 #代謝機能障害関連脂肪性肝疾患（#MASLD）を究める』です。
締め切りは7/31です。
皆様の応募をお待ちしております🎉🎉🎉https://t.co/G2HLWEoQcR

[日本肝臓学会 @JSHLiver]

【学会誌】日本肝臓学会和文誌「肝臓」5月号が発刊されました📖
👉https://t.co/GT1VB0zKXs

▶️肝硬変におけるアンモニアの臨床的意義～静脈血アンモニア濃度は，肝性脳症，特に不顕性肝性脳症の病態を正確に反映しているか？～
👉https://t.co/WFkhJFUzrc

▶️地域コホートにおけるアンケート調査を用いた新規HCV拾い上げ戦略
👉https://t.co/rdKe9PqD9K

▶️郵送通知による肝炎ウイルス検査陽性者の医療再接続支援とマイクロエリミネーションへの展開
👉https://t.co/pjQhVg19X9

▶️乳癌治療薬アベマシクリブによるdrug-induced autoimmune-like hepatitisが疑われた1例
👉https://t.co/2de2dYZpXi

▶️アテゾリズマブ＋ベバシズマブ併用療法中に多発関節炎および高ビリルビン血症を呈し，ステロイド治療が奏効した肝細胞癌の一例
👉https://t.co/0OxAQNjib0

▶️腹膜炎に続発し肝外からの炎症波及により発症，治療に難渋した肝炎症性偽腫瘍の一例―NSAIDsの治療的可能性を契機とした経過を通して―
👉https://t.co/0YFu8rXXoX

▶️超高齢者に発症したリスク因子陰性・非肝硬変性肝細胞癌の1例
👉https://t.co/QpjFSwo9nB

▶️免疫チェックポイント阻害薬投与後に出現し，免疫関連有害事象との鑑別が困難であったC型慢性肝炎の急性増悪の一例
👉https://t.co/iWLAROgt3U

▶️愛媛県中予地区におけるB型肝炎ウイルスキャリアの遺伝子型の現状
👉https://t.co/wK6moAdD97

▶️一次医療におけるFIB-4 indexの年齢依存性と高齢者での高値判定増加―地域一次医療における118,556例の横断解析―
👉https://t.co/Zbe6lvYnAF

[Hepatology Research @HepatolRes]

▶️Animal Naming Test Can Identify Covert Hepatic Encephalopathy in Patients With Cirrhosis With Limited Influence From Age or Educational Level

👉https://t.co/B1IgSe7snU

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

#SpecialReport
▶️Liver Transplantation in Japan: Registry by the Japanese Liver Transplantation Society

👉https://t.co/HcjUkZV3Wc

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

#Review
▶️The Microbiome-Gut-Liver Axis Drives Post-Kasai Fibrosis in Biliary Atresia: From Mechanism to Precision Intervention

👉https://t.co/P5WK3NhRYA

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

#Editorial
▶️Endoscopic Variceal Therapy and Transitional Care in Pediatric Portal Hypertension: A Review With a Focus on Long-Term Outcomes and Adherence

👉https://t.co/bgX6qwXw5W

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

#Editorial
▶️Dual Escape From Ferroptosis and Disulfidptosis Denotes a Hypermetabolic, High-Risk Subtype of Hepatocellular Carcinoma

👉https://t.co/sKacw56naS

#LiverX @WileyHealth

[Hepatology Research @HepatolRes]

#Editorial
▶️Platelets as Context-Dependent Modulators of Hepatic Microvascular Injury in Metabolic Dysfunction–Associated Steatotic Liver Disease

👉https://t.co/LZhSDIFNFm

#LiverX @WileyHealth